AMICUS THERAPEUTICS, INC. — Director's Dealing 2014

Aug 21, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2014-08-20

Reporting Person: Gershkowitz Jayne (VP, Patient Advocacy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-20	Common stock	P	6080	$5.40	Acquired	56080	Direct
2014-08-20	Common stock	S	6080	$5.40	Disposed	50000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-20	Stock Options (right to buy)	$2.81	M	6080	Disposed	2020-06-15	Common Stock (6080)	Direct

Footnotes

F1: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2014.